(Q38467778)

3 September 2017

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients (English)

1 reference

3 September 2017

1 reference

Roth D

1

1 reference

3 September 2017

Smith RD

2

1 reference

3 September 2017

Schulman G

3

1 reference

3 September 2017

Steinman TI

4

1 reference

3 September 2017

Hatch FE

5

1 reference

3 September 2017

Rudnick MR

6

1 reference

3 September 2017

Sloand JA

7

1 reference

3 September 2017

Freedman BI

8

1 reference

3 September 2017

Williams WW Jr

9

1 reference

3 September 2017

Shadur CA

10

1 reference

3 September 2017

1 November 1994

1 reference

American Journal of Kidney Diseases

3 September 2017

1 reference

3 September 2017

24

1 reference

3 September 2017

5

1 reference

3 September 2017

777-784

1 reference

Effect of recombinant human erythropoietin on renal function in humans

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Measurement of renal function in chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Efficacy and side effects of erythropoietin used in the treatment of anemia of uremic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Prospective randomised trial of early dietary protein restriction in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Phosphate depletion arrests progression of chronic renal failure independent of protein intake

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

A method for estimating nitrogen intake of patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Analysis of Growth and Dose Response Curves

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

A simple method of estimating progression of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Dynamics of glomerular ultrafiltration in the rat. VIII. Effects of hematocrit

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Effect of recombinant human erythropoietin on muscle energy metabolism in patients with end-stage renal disease: a 31P-nuclear magnetic resonance spectroscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980671-8

7 January 2021

10.1016/S0272-6386(12)80671-8

Identifiers

DOI

1 reference

3 September 2017

1 reference